Qiagen: Lawrence Rosen
Qiagen has appointed Lawrence Rosen as the chairman of the firm's supervisory board. He will replace Håkan Björklund, who will step down as chairman and as a member of Qiagen's supervisory board.
Rosen currently has served as a member of Qiagen's supervisory board since 2013. He also serves on the supervisory board of German firm Lanxess. Rosen previously served as a member of the board of management and CFO at Deutsche Post DHL Group until 2016. Prior to that, he held the role of CFO of Fresenius Medical Care from 2003 to 2009. Prior to Fresenius Medical Care, Rosen was senior VP and treasurer for Aventis. Between 1984 and 2000, he held various positions at Avenis predecessor companies Hoechst and American Hoechst/Hoechst Celanese.
Becton Dickinson: Kristen Stewart
Becton Dickinson has appointed Kristen Stewart to the newly created position of Senior Vice President of Strategy and Investor Relations, reporting to BD's CFO Chris Reidy. Stewart will work with the BD executive team beginning Aug. 31 to drive shareholder value and to deliver and communicate the company's long-term growth strategy, BD said in a statement. Stewart has worked with investment banks for nearly two decades as a healthcare analyst specializing in medical technology, most recently leading the medical technology research division at Barclays Capital.
Illumina: Karen McGinnis
Illumina VP and Chief Accounting Officer Karen McGinnis has notified the firm that she will retire April 2, 2021.
For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.